Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antioxidants Effect Equivalent To Placebo In WAVE Trial, CRN Maintains

This article was originally published in The Tan Sheet

Executive Summary

The Women's Angiographic Vitamin & Estrogen (WAVE) trial "showed no difference in artery blockage" between the group taking high doses of vitamins C and E and controls, according to the Council for Responsible Nutrition

You may also be interested in...



Antioxidant Supplementation Delayed Effects To Be Followed In UK Study

High-risk subjects in a UK intervention trial, which found no preventive effects of antioxidant vitamins against various diseases, will be monitored to determine if benefits surface after the initial study period

Vitamins C, E, Selenium Upper Limits Set For First Time By FNB

The Institute of Medicine's Food & Nutrition Board announced selenium upper intake limits for the first time, setting the maximum safe intake amount at 400 mcg/day. The last review of safe and effective intake levels for antioxidants by the National Academy of Sciences group was in 1989.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS094809

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel